Total Payments
$41,802
2024 Payments
$7,396
Companies
6
Transactions
28
Payment Breakdown by Category
Consulting$33,133 (79.3%)
Other$7,800 (18.7%)
Food & Beverage$586.35 (1.4%)
Travel$281.95 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $33,133 | 13 | 79.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,920 | 3 | 16.6% |
| Honoraria | $880.00 | 1 | 2.1% |
| Food and Beverage | $586.35 | 9 | 1.4% |
| Travel and Lodging | $281.95 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $25,367 | 16 | $0 (2024) |
| SERVIER PHARMACEUTICALS LLC | $6,410 | 3 | $0 (2024) |
| Amgen Inc. | $6,396 | 3 | $0 (2022) |
| Sumitomo Dainippon Pharma Co., Ltd. | $2,285 | 4 | $0 (2021) |
| Chugai Pharmaceutical Co., Ltd. | $1,320 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $23.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,396 | 6 | JAZZ PHARMACEUTICALS INC. ($5,746) |
| 2023 | $7,608 | 5 | JAZZ PHARMACEUTICALS INC. ($7,608) |
| 2022 | $6,353 | 4 | JAZZ PHARMACEUTICALS INC. ($4,553) |
| 2021 | $16,976 | 8 | JAZZ PHARMACEUTICALS INC. ($7,460) |
| 2020 | $2,040 | 1 | Servier Pharmaceuticals LLC ($2,040) |
| 2017 | $1,428 | 4 | Sumitomo Dainippon Pharma Co., Ltd. ($1,405) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $5,544.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/07/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug), VYXEOS, Defitelio | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $73.49 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/09/2024 | SERVIER PHARMACEUTICALS LLC | Asparlas (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Oncology | ||||||
| 12/18/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,120.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/10/2023 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $147.01 | General |
| 12/08/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $99.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/12/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $41.46 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/25/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/19/2022 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $2,560.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/27/2022 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $1,920.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/07/2022 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $73.10 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/16/2022 | Amgen Inc. | Blincyto (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Oncology | ||||||
| 12/02/2021 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $2,596.00 | General |
| Category: Oncology | ||||||
| 10/29/2021 | Sumitomo Dainippon Pharma Co., Ltd. | — | Honoraria | Cash or cash equivalent | $880.00 | General |
| Category: CNS | ||||||
| 08/20/2021 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/13/2021 | Amgen Inc. | Kyprolis (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 03/27/2021 | Chugai Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $1,320.00 | General |
| 03/12/2021 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/20/2021 | Servier Pharmaceuticals LLC | ASPARLAS (Drug) | Consulting Fee | Cash or cash equivalent | $2,720.00 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2021 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/02/2020 | Servier Pharmaceuticals LLC | — | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| 06/22/2017 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: ONCOLOGY | ||||||
About Dr. Hiroto Inaba, MD
Dr. Hiroto Inaba, MD is a Pediatric Hematology-Oncology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356533046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hiroto Inaba, MD has received a total of $41,802 in payments from pharmaceutical and medical device companies, with $7,396 received in 2024. These payments were reported across 28 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($33,133).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Memphis, TN
- Active Since 08/16/2007
- Last Updated 09/28/2012
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1356533046
Products in Payments
- RYLAZE (Drug) $25,220
- Blincyto (Biological) $4,396
- ASPARLAS (Drug) $2,720
- Kyprolis (Drug) $2,000
- Asparlas (Drug) $1,650
- ambizome (Drug) $1,405
- KYMRIAH (Biological) $23.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Memphis
Dr. Scott Howard, Md, MD
Pediatric Hematology-Oncology — Payments: $1.8M
Pediatric Hematology-Oncology $1.8M
Dr. Ellis Neufeld, Md, MD
Pediatric Hematology-Oncology — Payments: $415,947
Pediatric Hematology-Oncology $415,947
Dr. Deepa Manwani, M.d, M.D
Pediatric Hematology-Oncology — Payments: $184,525
Pediatric Hematology-Oncology $184,525
Gary Myers, Md, MD
Pediatric Hematology-Oncology — Payments: $132,626
Pediatric Hematology-Oncology $132,626
Mr. Alberto Pappo, M.d, M.D
Pediatric Hematology-Oncology — Payments: $93,631
Pediatric Hematology-Oncology $93,631
Dr. Ching-Hon Pui, Md, MD
Pediatric Hematology-Oncology — Payments: $86,478
Pediatric Hematology-Oncology $86,478